IONS
Ionis Pharmaceuticals, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #549
- Final score
- 48.29
- Years on list
- 7
↗ Climbed 370 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 370 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 197 since 2021
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 72 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | IONS | RPRX | IQV |
|---|---|---|---|
| Climate Change | 57.5 | 57.2 | 75.8 |
| Employee Relations | 45.0 | 51.4 | 43.5 |
| Environment | 50.4 | 17.7 | 21.3 |
| Stakeholders & Society | 57.1 | 68.2 | 59.8 |
| Human Rights | 18.7 | 42.0 | 28.8 |
| Governance | 43.5 | 46.5 | 49.8 |
| Performance Rating | 63.3 | 77.7 | 45.2 |